Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
To the Editor, Epstein–Barr virus (EBV) viremia and EBV-related post-transplant lymphoproliferative disorder (PTLD) remain major complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT), occurring in approximately 30–60% and 1–10% of recipients, respectively, and reaching 70–80% and >15% in high-risk populations; PTLD mortality exceeds 50% [1,2,3,4].
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.